Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

Viron and Ocean Begin Trial of Immunotherapy as Functional Cure for HBV

publication date: Oct 27, 2023

Virion Therapeutics and its JV partner, Ocean Biomedical, have begun a Phase 1b clinical trial of VRON-0200 in Hong Kong and New Zealand. An immunotherapy, VRON-0200 aims to be a functional cure for patients with chronic Hepatitis B virus (HBV) infection by overcoming immune exhaustion. VRON-0200 is a first-in-class treatment based on a Virion proprietary checkpoint modifier that is designed to broaden a patient's own immune response. Virion, a Philadelphia biotech, develops novel T cell-based immunotherapies, while Ocean Bio of Providence, RI, accelerates novel drug candidates from academic and company researchers into approved drugs. More derails....

Stock Symbol: (NSDQ: OCEA)

Share this with colleagues:  


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital